BENERVA 500 mg/5 ml, solution for injection (IM and IV) in an ampoule 10 ampoules of 5 ml
Active ingredients: Thiamine hydrochloride
Commercialized according to BDPM
Solution for injection10 ampoules of 5 mlintramusculaire;intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BENERVA 500 mg/5 mL, solution injectable (IM et IV) en ampoule
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire;intraveineuse
- Presentation description
- 10 ampoule(s) en verre de 5 ml
- Marketing authorisation holder
- TEOFARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 27 Jan 2026
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68412875CIP75510930CIP133400955109303Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE THIAMINEsolution | 500,00 mg · une ampoule de 5 mL | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.